ADMA Biologics, Inc. Under Investigation for Securities Fraud and Impact…
Investors of ADMA Biologics, Inc. (NASDAQ: ADMA) should take note that the Schall Law Firm is currently looking into potential securities law violations by the company. It has been alleged that the company misled the market with false information. Notably, on October 9, 2024, ADMA Biologics disclosed the sudden departure of their independent outside auditor, CohnReznick LLP. This news caused the company’s shares to drop by more than 16.3% the following day.
If you are an investor who experienced losses as a result, you are encouraged to reach out to Brian Schall at the Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. You can contact him at 310-301-3335 to discuss your rights at no cost. Alternatively, you can visit the firm’s website at www.schallfirm.com or email bschall@schallfirm.com. The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors from across the globe.
It’s important to note that this press release may be considered Attorney Advertising in specific jurisdictions based on applicable laws and ethics rules. For further information, reach out to:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com
Source: The Schall Law Firm
Please remember that the Markets Insider and Business Insider Editorial Teams were not involved in developing this post. Stay informed and exercise your rights as an investor if you have been impacted.
